Page last updated: 2024-11-07

prednisone and Lymphangioendothelioma, Malignant

prednisone has been researched along with Lymphangioendothelioma, Malignant in 1 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research Excerpts

ExcerptRelevanceReference
"The principles of treatment for hemangiomas based upon our clinical classification are discussed and may be summarized as follows: 1."2.36Vascular and lymphatic tumors in infancy, childhood and adulthood: challenge of diagnosis and treatment. ( Edgerton, MT; Hiebert, JM, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edgerton, MT1
Hiebert, JM1

Reviews

1 review available for prednisone and Lymphangioendothelioma, Malignant

ArticleYear
Vascular and lymphatic tumors in infancy, childhood and adulthood: challenge of diagnosis and treatment.
    Current problems in cancer, 1978, Volume: 2, Issue:7

    Topics: Adult; Angiomatosis; Arteriovenous Malformations; Blood Coagulation Disorders; Child; Female; Gigant

1978